Comparison of citrate dialysate in pre- and post-dilution online hemodiafiltration: effect on clot formation and adequacy of dialysis in hemodialysis patients
- PMID: 38189095
- PMCID: PMC10776067
- DOI: 10.1080/0886022X.2024.2302109
Comparison of citrate dialysate in pre- and post-dilution online hemodiafiltration: effect on clot formation and adequacy of dialysis in hemodialysis patients
Abstract
Background: Citrate dialysate (CD) has been successfully used in conventional hemodialysis and continuous renal replacement therapy; however, no study has compared pre- and post-dilution online hemodiafiltration (oL-HDF). Therefore, we aimed to investigate the efficacy of citrate anticoagulation for oL-HDF and the metabolic changes and quality of life of patients on hemodialysis treated using both modes.
Method: Eight dialysis patients were treated with CD containing 0.8 mmol of citric acid for 4 weeks in each phase. Visual clotting scores were investigated as the primary endpoints. Adequacy of dialysis, laboratory parameters, and quality of life were measured as secondary objectives.
Results: The mean clotting scores in the pre-dilution mode were significantly lower than those in the post-dilution mode and in all phases except the heparin-free phase (p < 0.001 in the baseline phase, p = 0.001 in phase 1, and p = 0.023 in phase 2). The values of Kt/V in both modalities were comparable except during the baseline phase, in which the values of pre-dilution were significantly greater than post-dilution (2.36 ± 0.52/week vs. 1.87 ± 0.33/week;95% CI -0.81 to -0.19, p = 0.002). The patient's quality of life regarding their physical activity level was significantly higher in the post-dilution mode than in the pre-dilution mode at baseline and in phase 1 (p = 0.014 and 0.004 at baseline and in phase 1, respectively). Metabolic changes did not differ between the two modes.
Conclusion: Citrate dialysate decreased or prevented anticoagulation in both pre- and post-dilution modes of oL-HDF without significant side effects and had comparable adequacy of dialysis.
Keywords: Adequacy of dialysis; citrate dialysate; clot formation; hemodialysis; online hemodiafiltration; post- dilution; pre-dilution.
Conflict of interest statement
No potential conflict of interest was reported by the author(s).
Figures



Similar articles
-
Citrate-Buffered Dialysis Solution (Citrasate) Allows Avoidance of Anticoagulation During Intermittent Hemodiafiltration-At the Cost of Decreased Performance and Systemic Biocompatibility.Artif Organs. 2017 Aug;41(8):759-766. doi: 10.1111/aor.12851. Epub 2016 Nov 10. Artif Organs. 2017. PMID: 27859427
-
Citrate anticoagulation for postdilutional online hemodiafiltration with calcium-containing dialysate and infusate: significant clotting in the venous bubble trap.Int J Artif Organs. 2008 Apr;31(4):323-8. doi: 10.1177/039139880803100408. Int J Artif Organs. 2008. PMID: 18432588 Clinical Trial.
-
Comparison of the pre-dilution and post-dilution methods for online hemodiafiltration.J Artif Organs. 2024 Mar;27(1):48-56. doi: 10.1007/s10047-023-01391-2. Epub 2023 Apr 3. J Artif Organs. 2024. PMID: 37010653
-
Updates on hemodialysis techniques with a common denominator: The personalization of the dialytic therapy.Semin Dial. 2021 May;34(3):183-195. doi: 10.1111/sdi.12956. Epub 2021 Feb 16. Semin Dial. 2021. PMID: 33592133 Review.
-
Why choose high volume online post-dilution hemodiafiltration?J Nephrol. 2017 Apr;30(2):181-186. doi: 10.1007/s40620-016-0343-0. Epub 2016 Sep 1. J Nephrol. 2017. PMID: 27586123 Review.
Cited by
-
Short-term effect of low-dose roxadustat combined with erythropoiesis-stimulating agent treatment for erythropoietin-resistant anemia in patients undergoing maintenance hemodialysis.Front Endocrinol (Lausanne). 2024 Jul 1;15:1372150. doi: 10.3389/fendo.2024.1372150. eCollection 2024. Front Endocrinol (Lausanne). 2024. PMID: 39010898 Free PMC article.
-
SOLFA study: a multicenter, open-label, prospective, randomized study to investigate the clotting propensity of asymmetric cellulose triacetate membrane compared to synthetic membranes in on line HDF.J Nephrol. 2025 Mar;38(2):697-705. doi: 10.1007/s40620-024-02197-y. Epub 2025 Jan 19. J Nephrol. 2025. PMID: 39827429 Free PMC article. Clinical Trial.
-
Switching from acetate to citrate dialysate in a central concentrate delivery system for high-volume online hemodiafiltration: a retrospective cohort study.Ren Fail. 2024 Dec;46(2):2398709. doi: 10.1080/0886022X.2024.2398709. Epub 2024 Sep 9. Ren Fail. 2024. PMID: 39252176 Free PMC article.
References
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical